Medical and Pharmaceutical Breath Diagnostics gives the public the chance to join the fight against cancer Regulation crowdfunding allows a startup or private company to reach out directly to the public for support Joseph Morton14 hours ago
Medical and Pharmaceutical Breath Diagnostics now offering a compelling investment opportunity The lung cancer breath test developer is enabling investors to buy US$3 shares through a Reg CF financing Rowan Dunne15 hours ago
Medical and Pharmaceutical Could robots be the solution to lung cancer imaging woes? The institute is looking to implement a marriage between robotic bronchoscopy and advanced imaging technology Joseph Morton2 days ago
Medical and Pharmaceutical CG Oncology shares jump on positive clinical trial data for cancer drug The U.S. Food and Drug Administration (FDA) granted cretostimogene Fast Track and Breakthrough Therapy designations Joseph MortonApril 28, 2025
AI and Autonomy Alibaba Group gets FDA nod for cancer detection tool The tool can effectively detect early-stage cancers in asymptomatic patients Joseph MortonApril 24, 2025
Medical and Pharmaceutical Alarming CT radiation study highlights need for alternative diagnostic tools University of California researchers have determined that these machines can cause 1 out of every 20 new cancer cases Rowan DunneApril 15, 2025
Medical and Pharmaceutical How could a simple blood test could eliminate tumour biopsies? The company has received support from the Centre of Expertise in Advanced Materials and Sustainability and Innovate UK Joseph MortonApril 15, 2025
Medical and Pharmaceutical Lung cancer breath test demonstrates remarkable efficacy in Dutch study It correctly identified positive cases with 80 to 92% accuracy Rowan DunneApril 14, 2025
Medical and Pharmaceutical Smokers skipping lung cancer screenings: study Lung cancer remains the leading cause of cancer death in the United States Joseph MortonApril 10, 2025
Medical and Pharmaceutical Median Technologies clears hurdle on the way to regulatory acceptance in EU and US The company has met a key requirement for regulatory submissions in the US and Europe Joseph MortonApril 3, 2025